Lifecore (LFCR) Biomedical announced that it has entered into a sales agreement with a non-competitive buyer for the company’s previously purchased, but not yet installed, high-speed, multi-purpose 10-head isolator filler. Under the terms of the agreement, the buyer will pay Lifecore an aggregate purchase price of $17M in exchange for the 10-head filler. Lifecore received $7M at closing and anticipates receiving the remaining payments in three tranches over the next 18 months.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFCR:
- Lifecore Biomedical Reports Q2 Fiscal 2025 Results
- Closing Bell Movers: Resources Connection gains 5% on earnings
- Lifecore Biomedical reports Q2 EPS (25c), two estimates (31c)
- Options Volatility and Implied Earnings Moves Today, January 02, 2025
- LFCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue